Evidence map›Paper›PMID 42174714›Full record

ArticleBMC chemistry2026

Greenness profile assessment of a novel pioneer approach for voltametric sensing of cloperastine fendizoate in a pharmaceutical dosage form.

Maha Mahmoud Abou El-Alamin, Ola Abd Elkhalek, Marwa M Azab

Abstract read
In one paragraph

Article in BMC chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maha Mahmoud Abou El-AlaminDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Helwan University, P.O.Box 11795, Cairo, Egypt.
Ola Abd ElkhalekDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Helwan University, P.O.Box 11795, Cairo, Egypt. Ola.abdelkhalek@pharm.helwan.edu.eg.
Marwa M AzabDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Helwan University, P.O.Box 11795, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel sustainable analytical approach based on an electrochemical sensor has been fabricated for the quantification of Cloperastine Fendizoate (CLP), which has recently been employed in the management of COVID-19. A carbon paste electrode modified with 2% multiwalled carbon nanotubes and 1% chitosan (2%MWCNT/1%Chitosan/CPE) was fabricated to implement the proposed procedure. The obtained results demonstrated irreversible oxidation behavior and diffusion-controlled oxidation process of CLP, characterized by a well-defined anodic peak (E/V = 0.8) in 0.2 M phosphate buffer at pH 8 utilising differential pulse voltammetry (DPV). A linear correlation between current signal and CLP concentration was obtained across the range of 7.500 × 10

Indexed as

Cloperastin fendizoateCOVID-19Differential Pulse voltammetryGreen analytical chemistryModified Carbon Paste Electrode

Identifiers

PMID42174714
PMCPMC13198058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.